在患有心脏代谢风险因素的患者中,运动对左心室重塑的影响
Evanthia Bletsa1,2, Evangelos Oikonomou1,2, Kyriakos Dimitriadis3
13rd Department of Cardiology, National and Kapodistrian University of Athens, Medical School, Sotiria Chest Disease Hospital, 11527 Athens, Greece.
Life (Basel, Switzerland)
|August 26, 2023
概括
运动训练可以通过影响左心室 (LV) 改造来改善心力衰竭 (HF) 和心脏代谢风险因素 (如高血压,2型糖尿病 (T2D) 和肥胖) 的患者的心脏功能和预后.
科学领域:
- 心脏病学 心脏病学
- 运动生理学 运动生理学
- 代谢疾病 代谢疾病
背景情况:
- 左心室 (LV) 改造,心脏大小,形状和厚度的变化,加剧了心力衰竭 (HF) 的结果.
- 高血压,2型糖尿病 (T2D) 和肥胖是LV重塑,高和功能障碍的关键驱动因素.
- 运动训练被证明有利于心血管疾病 (CVD) 的预防和管理.
研究的目的:
- 对患有心脏代谢风险因素的患者的LV重塑的证据进行审查.
- 要突出关于运动训练对这些人群中LV重塑的影响的研究.
主要方法:
- 对LV重塑研究的文献综述.
- 对高血压,T2D和肥胖患者的运动训练干预措施的分析.
主要成果:
- 运动训练可以改善CAD和HF患者的功能能力,心脏功能和生物标志物.
- 运动训练对LV重塑和心脏预后有积极的影响.
结论:
- 运动训练在减轻患有心脏代谢风险因素的患者不良LV重塑方面显示出有前途.
- 进一步的研究可以优化炼方案来管理LV重塑和改善心血管结果.
更多相关视频
相关概念视频
Heart Failure II: Pathophysiology
15
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
Exercise and Cardiovascular Response
861
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
861
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K


